Search research articles
Contact Us
Filters
Showing results (231-240 of 550) with videos related to
Page
of 55
Sort By:
American Journal of Clinical Oncology
|
March 7, 2018
Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial
Nuria Kotecki, Axel Le Cesne, Emmanuelle Tresch-Bruneel, et al.
Oncology
|
July 8, 2011
Final results of ERASME-4: a randomized trial of first-line docetaxel plus either capecitabine or epirubicin for metastatic breast cancer
Thomas Bachelot, Agathe Bajard, Isabelle Ray-Coquard, et al.
International Journal of Environmental Research and Public Health
|
October 13, 2018
Geographical Accessibility of the Referral Networks in France. Intermediate Results from the IGéAS Research Program
Yohan Fayet, Jean-Michel Coindre, Cécile Dalban, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 12, 2012
Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas
Irène Asmane, Emmanuel Watkin, Laurent Alberti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas
Martee L Hensley, Brigitte A Barrette, Klaus Baumann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2019
Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study
Olivier Colomban, Michel Tod, Alexandra Leary, et al.
Bulletin Du Cancer
|
August 12, 2023
Jérôme Alexandre, Marie-Aude Le Frère-Belda, Antoine Angelergues, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043)
Stefan Sleijfer, Isabelle Ray-Coquard, Zsuzsa Papai, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
February 13, 2026
Pierre-Yves Meunier, Karfala Maiga, Denis Maillet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2010
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)
Axel Le Cesne, Jean-Yves Blay, Binh Nguyen Bui, et al.
Page
of 55
Search research articles
Search
Showing results (231-240 of 550) with videos related to
Sort By:
Page
of 55
American Journal of Clinical Oncology
|
March 7, 2018
Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial
Nuria Kotecki, Axel Le Cesne, Emmanuelle Tresch-Bruneel, et al.
Oncology
|
July 8, 2011
Final results of ERASME-4: a randomized trial of first-line docetaxel plus either capecitabine or epirubicin for metastatic breast cancer
Thomas Bachelot, Agathe Bajard, Isabelle Ray-Coquard, et al.
International Journal of Environmental Research and Public Health
|
October 13, 2018
Geographical Accessibility of the Referral Networks in France. Intermediate Results from the IGéAS Research Program
Yohan Fayet, Jean-Michel Coindre, Cécile Dalban, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 12, 2012
Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas
Irène Asmane, Emmanuel Watkin, Laurent Alberti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas
Martee L Hensley, Brigitte A Barrette, Klaus Baumann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2019
Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study
Olivier Colomban, Michel Tod, Alexandra Leary, et al.
Bulletin Du Cancer
|
August 12, 2023
Jérôme Alexandre, Marie-Aude Le Frère-Belda, Antoine Angelergues, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043)
Stefan Sleijfer, Isabelle Ray-Coquard, Zsuzsa Papai, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
February 13, 2026
Pierre-Yves Meunier, Karfala Maiga, Denis Maillet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2010
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)
Axel Le Cesne, Jean-Yves Blay, Binh Nguyen Bui, et al.
Page
of 55